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Abstract: The structure of 3-bromomethyl-2-chloro-quinoline crystallizes in the triclinic crystal space group P‘1 with
unit cell parameters a=6.587(2), b=7.278(3), c=10.442(3) Å, a= 83.59(3)°, b= 75.42(2)°, g= 77.39(3)°, Z= 2, V=
471.9(3)Å3. The structure has converged to a final R-value of 0.0734. The phenyl Ring-B has normal geometry while
the pyridine Ring-A has slightly distorted conformation. The asymmetry parameter calculations, i.e., DC2 and DCs for
the pyridine ring indicates that the structure is planar. There exists one intramolecular hydrogen bonded interaction
of the type C-H…Cl and one C-H…N intermolecular interaction. The structure is stabilized by Van der Waals forces.
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INTRODUCTION
Quinoline is a heterocyclic aromatic organic compound
characterized by a two- ring structure in which the
benzene ring is fused to pyridine moiety. Quinolines and
their derivatives are important scaffolds because of their
wide spectrum of biological activities (Saito et al., 2001;
Lekhok et al., 2008). They are used as efficient drugs for
the treatment of malaria (Robert et al, 1998; Palani et al,
2004) and possess antibacterial, antiarrhythmic,
antihypertensive and antibiotic properties as well.
Quinoline alkaloids also act as immuno-suppressant
inhibitors and virucides (Gilchrist et al., 1997; Kouznetsov
et al., 1998; Garcia et al., 2000).
MATERIALS AND METHODS
The title compound is a heterocyclic quinoline derivative
which has been synthesized by conventional chemical
procedures. The chemical structure, as shown in Fig. 1,
has been established on the basis of IR, UV, NMR and
mass spectral data. The experimental procedure adopted
for activity and X-ray structure analysis is presented in
the following sections.
(i)  Activity Determination: The activity of the molecule
has been determined by making use of PASS software
(Poroikov et al., 2005). The input for activity determination
is the molecular fragment which undergoes computation
against a large number of known / reported activities.
The information which can be deduced from the
computational process is the probability of a given
molecule to be “active” or “inactive” on a scale of 0 to 1.
The probabilities are generally referred to as Pa and Pi.
These values provide us a way to suggest possible drug
likeness for a given molecule on the basis of a
comparative analysis of the activity data. This helps us
to have a relationship between the structure and its
activity. From the activity analysis, it has been found
that the title compound has 23 substructure descriptors,
and exhibits five possible activities at Pa >P i.  The
probability of drug likeness for the investigated molecule
is 0.056.  The details of the activities are presented in
Table 1.
(ii)  X-ray Crystallography: A single crystal having a
well-defined morphology was selected for three-
dimensional crystal intensity data collection on a
computer-controlled single crystal X-ray diffractometer
(X’calibur  system – Oxford diffraction-make, U.K) by
using MoKa radiation (?= 0.71073Å). The data were
collected by using CrysAlis Pro (2007) software. A total
number of 4003 reflections were recorded of which 2529
reflections were found   unique having index range: -9£ h
£9, -10£ k £9, -14£ l £14). The data were reduced by using
CrysAlisRED (2007).
The structure has been obtained by employing direct
methods using SHELXS86 software (Sheldrick, 1986). All
non- hydrogen atoms of the molecule were located from
the E-map (electron density map).  Refinement has been
carried out by full-matrix least-squares method on F2 using
SHELXL97 software (Sheldrick, 1997). The anistropic
refinements with thermal parameters for non-hydrogen
atoms and subsequent refinement cycles converged the
R-factor to 0.0734. The maximum and minimum residual
electron density is 1.027 and -0.994 e.Å -3, respectively.
The crystallographic data are listed in Table 2.
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Pa (Probability 
of the 
molecule to be 
active) 
Pi (Probability 
of the 
molecule to be 
inactive) 
Possible Activities  
0.080 0.030 Saluretic 
0.097 0.047 Phosphodiesterase IV 
inhibitor 
0.037 0.008 Angiotensin antagonist 
0.035 0.008 Angiotensin II receptor 
antagonist 
0.029 0.013 Angiotensin AT1 receptor 
antagonist 
 
Table 1. Details of the activities.
Molecular formula                                 C10 H7 Br Cl N 
Formula weight 256.53 
Temperature 293(2) K 
Wavelength (MoKa) 0.71073Å 
Crystal system, space group Triclinic, P`1 
Unit cell dimensions                                            a = 6.587(2)Å,   a= 83.59(3)° 
 b = 7.278(3)Å,   b= 75.42(2)° 
 c = 10.442(3)Å, g=  77.39(3)° 
Volume 471.9(3) Å3 
No. of molecules per unit cell(Z) 2 
Calculated density 1.805 Mg/m3 
Absorption coefficient 4.584 mm -1 
F(000)                                                                        252
Crystal size 0.30  x 0.25  x 0.20 mm 
Theta range for data collection 3.26 to 30.25° 
Limiting indices  -9£h£9, -10£k£9, -14£l£14 
Reflections collected / unique  4003/2529 [R(int)=0.0415] 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 2529 / 0 / 143 
Goodness-of-fit on F2 1.094 
Final R indices [I>2s(I)] R1 = 0.0734, wR2 = 0.1851 
R indices (all data) R1 = 0.0917, wR2 = 0.2013 
Extinction coefficient 0.003(5) 
Largest diff. peak and hole 1.027 and -0.994 e. Å -3 
 
Table 2:  Crystal data and structure refinement details.
Fig. 2. ORTEP view of the full molecule (thermal ellipsoids
drawn at 50%  probability level).
Fig. 1. Chemical structure of 3-bromomethyl-2-chloroquinoline.
RESULTS AND DISCUSSION
The final atomic coordinates and equivalent isotropic
thermal factors for all the non-hydrogen atoms are listed
in Table 3. Bond distances and bond angles for non-
hydrogen atoms are listed in Table 4. Torsion angles for
non-hydrogen atoms are listed in Table 5. An ORTEP
view of the molecule indicating atomic numbering scheme
(thermal ellipsoids drawn at 50% probability level), is
shown in Fig. 2 (Farrugia, 1997). The geometrical
calculations have been performed using PARST program
(Nardelli, 1995).
The molecule consists of two six-membered rings which
are labeled as Ring-A and B, respectively. Ring- A is
chloroquinoline moiety while the Ring- B is the phenyl
(benzene) ring. In Ring-A, the bond distances show
significant deviation from the standard C-C and C-N
distances. The C1=N1 and N1-C5 distances of 1.283(7)
and 1.350(7) Å are deviated significantly from the
standard distances. The carbon-chlorine [C1-Cl] distance
of 1.734 (6) Å is comparable with the values as obtained
in an analogous structure of 2-chloro-3-(ß-
nitrovinyl)quinoline (Palani et al., 2004). The Br-C10
distance of 1.956(6) Å is quite close to the standard value
of 1.94 Å (Schneider et al., 2008). The C4-C5 bond acts as
a fusion bond between Ring-A and Ring- B which are
loaded symmetrically.
The endocyclic bond angle C1-N1-C5 [118.0(5) °] is
slightly inconsistent with the corresponding values
obtained for some analogous structures (Sudha et al.,
1995a; 1995b; Sudha et al., 1997; Rajnikant et al., 2002).
The shortening of this angle could be attributed to the
stretching which the carbon-chlorine [C1-Cl] bond might
have created in Ring-A. The endocyclic bond angle C1-
C2-C3 [115.7(5)°] is also short as compared to its usual
value of 120°. This could also be due to the location of –
CH2Br group at C2 position of the quinoline ring.  The
phenyl Ring- B has a very normal geometry in terms of
its bond distances and angles.
The dihedral angle between plane 1 [C1, C2, C3, C4, C5
and N1] and plane 2 [C4, C5, C6, C7, C8 and C9] of the
molecule is 179.07(1)°. This, more or less, is equal to 180°
(or 0°) which means that the molecule is strictly planar
and the individual rings do not exhibit any torsion along
C4-C5 bond. The magnitude of torsion along C2-C10   [i.e.,
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Table 3.  Atomic   coordinates   and   equivalent   isotropic temperature factors (Å) with e.s.d’s in parentheses, for non-hydrogen
atoms.
Table 4. Bond distances (Å) and angles (°) with e.s.d’s in parentheses for non-hydrogen atoms.
Ueq
*= (1/3)”i”jUijai
*aj
*(aiaj)
C1-C2-C10-Br = -82.03° and C3-C2-C10-Br = 99.39°] is
quite obvious as the –CH2Br group has free rotation of
the quinoline moiety at C2 position. In order to ensure
about the planarity of Ring-A, the asymmetry parameters
DC2 and DCs were calculated by using   CONFOR software
(Chand, 2008). The values for DC2 and DCs are 0.109773
and 0.53507, respectively. These calculations reveal the
planar character of the pyridine ring. These parameters
are based on the work of Duax and Norton (1975).
The molecules in the unit cell as packed along the a-axis
(Fig. 3) are placed in reversed orientations. Since all the
hydrogen atoms were located from the difference map,
their role in understanding molecular interactions becomes
all the more important. The bromine atoms are found to
be located strategically in such a way that when joined
through a line, they appear to be forming a one-
dimensional array passing through the centre of the unit
cell. There exists two hydrogen bonded interactions. The
C10-H10…Cl intramolecular hydrogen bond gives rise to
a virtual five membered ring; thus making the present
molecule look like a three ring structure. The C6-H6…N1
intermolecular hydrogen bond makes an extended
network amongst the stacked layers and this bonding
helps the molecules to acquire stability in the unit cell.
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Atom x y z U(eq)* 
Br 0. 2152(1) 0.2044(1) 0.4938(1) 0.0053(1) 
Cl 0.7571(3) 0.2843(3) 0.3359(2) 0.0054(1) 
N(1) 0.7547(7) 0.2218(7) 0.0995(5) 0.0032(1) 
C(1) 0.6311(9) 0.2798(8) 0.2095(5) 0.0031(1) 
C(3) 0.3172(9) 0.3340(7) 0.1348(5) 0.0030(1) 
C(2) 0.4070(9) 0.3408(7) 0.2356(5) 0.0029(1) 
C(4) 0.4431(9) 0.2694(7) 0.0117(5) 0.0031(1) 
C(10) 0.2775(11) 0.4119(9) 0.3638(6) 0.0037(1) 
C(9) 0.3632(13) 0.2565(10) -0.0970(7) 0.0043(1) 
C(5) 0.6648(9) 0.2138(7) -0.0019(5) 0.0030(1) 
C(7) 0.7089(14) 0.1355(10) -0.2224(7) 0.0051(2) 
C(6) 0.7954(11) 0.1460(8) -0.1212(6) 0.0041(1) 
C(8) 0.4916(15) 0.1921(10) -0.2108(7) 0.0055(2) 
Bond Lengths (Å)    
Br-C(10) 1.956(6) C(2)-C(10) 1.475(7) 
Cl-C(1) 1.734(6) C(4)-C(9) 1.387(8) 
N(1)-C(1) 1.283(7) C(4)-C(5) 1.402(8) 
N(1)-C(5) 1.350(7) C(9)-C(8) 1.339(11) 
C(1)-C(2) 1.410(8) C(5)-C(6) 1.395(8) 
C(3)-C(2) 1.341(8) C(7)-C(6) 1.338(10) 
C(3)-C(4) 1.410(8) C(7)-C(8) 1.378(12) 
Bond Angles(°)     
C(1)-N(1)-C(5) 118.0(5) C(5)-C(4)-C(3) 117.9(5) 
N(1)-C(1)-C(2) 126.4(5) C(2)-C(10)-Br 111.2(4) 
N(1)-C(1)-Cl 115.5(4) C(8)-C(9)-C(4) 121.6(7) 
C(2)-C(1)-Cl 118.0(4) N(1)-C(5)-C(6) 119.0(5) 
C(2)-C(3)-C(4) 120.9(5) N(1)-C(5)-C(4) 121.0(5) 
C(3)-C(2)-C(1) 115.7(5) C(6)-C(5)-C(4) 119.9(6) 
C(3)-C(2)-C(10) 121.4(5) C(6)-C(7)-C(8) 120.8(6) 
C(1)-C(2)-C(10) 122.9(5) C(7)-C(6)-C(5) 119.9(7) 
C(9)-C(4)-C(5) 117.5(6) C(9)-C(8)-C(7) 120.4(7) 
C(9)-C(4)-C(3) 124.6(6)   
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Table 6. Geometry of intermolecular and intramolecular hydrogen bond interactions (e.s.d’s in parentheses).
Fig. 3. Unit cell molecular packing along a-axis giving rise to
C6-H6…N1 hydrogen bonded network.
Table 5. Torsion angles (°) with e.s.d’s given in parentheses, for non-hydrogen atoms.
Fig.3 depicts the C6-H6…N1 intermolecular interaction
involved in infinite hydrogen bonded molecular network.
The geometry of both the hydrogen bonded interactions
is presented in Table 6.
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